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Pathogenesis of hypertension associated with chronic kidney dis-
ease without overt renal failure. C. Beret ta-Piccoli, P. Weidmann, R.
de Chafe! and F. C. Reubi. Policliniquede Mêdecine, Université de
Berne, Switzerland. Interrelations among blood pressure, ex-
changeable sodium, blood volume and plasma renin activity were
studied in 40 normal subjects and 40 patients with chronic kidney
disease and a mean plasma creatinine concentration of 2 mg/100
ml. Findings in eight normotensive patients did not differ from
those in normal subjects. However, 32 hypertensive patients
showed increases (P < 0.05) in exchangeable sodium and in the
products of the logarithm of plasma renin activity and exchange-
able sodium or blood volume. In the patients with renal disease,
blood pressure correlated significantly (P < 0.05) with duration of
hypertension (r = 0.70), exchangeable sodium (r = 0.34) and with
the exchangeable sodium-renin (r = 0.38) or blood volume-renin (r
= 0.30) products; but not with blood volume or circulating renin
individually. It correlated inversely with the glomerular filtration
rate (r = —0.33) and the para-aminohippurate (PAH) clearance (r
= —0.41). These findings suggest that hypertension accompanying
kidney disease without Overt renal failure may depend partly on
abnormalities in the sodium/volume-renin feedback mechanism as
well as a factor related to the duration of preexisting hypertension,
and possibly to the grade of renal vascular changes.
De novo membranous glomerulonephritis in two renal allografts.
P. Co/un, J. P. Saint-Andre, M. C. Gubler, R. Spiesser and P.
Riberi. Service de Nephrologie et Laboratoire d'A natomie Patholo-
gique, C,H.U. Angers, Cedex, France. A 35-year-old white woman
and a 10-yr-old boy with focal sclerosing glomerulonephritis, who
developed chronic renal failure, received cadaver renal allografts.
Four months later, massive, persistent proteinuria developed. The
renal tissue of homograft showed characteristic changes of mem-
branous glomerulonephritis. The criteria for de novo membranous
glomerulonephritis in renal allografts are met in these cases. In the
first case, the loss of renal function at the 19th month is suggestive
of chronic rejection of the renal allograft. In the second case, the
development of a membranous lesion in the transplanted kidney
secondary to the presence of hepatitis HB Ag cannot be excluded.
Brush border membrane fragments of the proximal tubule in hu-
man urine. M. E. De Broe, F. Roe/s. S. Ringoir and R. J. Wieme.
Departments of Nephrology. Anatomy, and Clinical Chemistry,
State University, Ghent, Belgium. Recently we adduced clinical,
biochemical and morphological evidence for the release of plasma
membrane fragments (PM F) into the circulation of patients with
cholestasis (De Broe ME, Weime Ri: C/in Chim Acta 59:369;
1975). Human urine was investigated in view of the fact that the
proximal tubule of the kidney, involved in transport process, could
be the source of a similar plasma membrane shedding. Urine of
normal subjects and of patients at onset of diuresis after acute
oligo-anuric renal failure was investigated. Proximal tubule brush
border enzymes (alkaline phosphatase, y-glutamyl-transferase, 5'-
nucleotidase, leucinaminopeptidase, maltase) were found to occur
in a macromolecular form which we had designated by the term
"koinozymes" referring to different enzymes occurring on a single
kinetic unit (Weime RJ, De Broe ME: C/in Chem 21:956, 1975).
This was shown by electrophoresis in different media and chroma-
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tography using Sepharose 4B. The density of these isolated koi-
nozymes was 1.205 determined after 24 hr of ultracentrifugation in
a 20, 25 or 30% CsCl gradient. The sodium dodecylsulfate poly-
acrylamide gel electrophoretic pattern of the isolated koinozymes
demonstrates several polypeptide chains (mol wt: > 300,000 to 22,
000). Lipid extraction followed by thin-layer chromatography re-
vealed cholesterol, free and esterified, and several types of phos-
pholipids. Electron microscopy of the macromolecular fractions
shows multiple vesicles bounded by a triple-layered membrane of
variable size, where the enzyme reaction product (alkaline
phosphatase) is contiguous to the outer surface of the membrane.
This result fits well with our earlier observations in the serum of
patients with cholestasis and recently in duodenal fluid and the
supernatant of cultured HeLa cells and lymphocytes. The signifi-
cance of this PMF release in the human urine remains to be
elucidated.
Physiological determinants of angiotensin II pressor responsive-
ness in normal subjects and in patients with terminal renal failure.
J. Deheneffe, V. Cuesia, J. D. Briggs, J. J. Brown, A. F. Lever, J. J.
Morton, W. Oelkers and J. I. S. Robertson. Department of internal
Medicine, University of Liege, Liege, Belgium and MRC Blood
Pressure Unit, Western infirmary, Glasgow, Scodand. Incremental
angiotensin II (A II) infusions were performed at doses of 2, 4, 8
and in some cases 12 ng . kg-1 . min for one hour each in ten
normal volunteers and in ten patients with terminal renal failure
(six anephrics). In five normal subjects, they were repeated after
three days of dietary Na depletion (10 to 15 mEq/24 hr) combined
with iv. administration of 40mg of frusemide, whereas all patients
with renal failure had a new infusion after three days of dietary Na
restriction combined with weight-reducing hemodialysis. When the
log of plasma A II concentrations was plotted against the corre-
sponding increases in diastolic blood pressure (DBP), there was a
shift to the right of the dose-response curves in the normal subjects
and in the "nephric" patients after Na depletion. Conversely, no
such phenomenon was observed in the anephrics, whose basal A II
levels were unchanged by Na depletion. In all cases, a direct
correlation was found between basal A II and the pressor thresh-
old. When increases in plasma A II concentration were plotted
against the corresponding rises in DBP, there was an inverse corre-
lation between the log of basal A II concentrations and the slopes
of the pressor A II dose-response curves. This relationship was not
significantly altered when the normal subjects only or the patients
with renal failure only were considered. No relationship could be
found between basal DBP and the corresponding slopes of the A II
pressor curves. The results suggest that (1) in anephric subjects
pressor responsiveness is not altered by isolated Na depletion (no
increase in A II concentration); (2) the inverse relationship be-
tween basal A 11 concentrations and the slopes of the pressor dose-
response curves to A II is not altered by chronic renal insufficiency;
(3) basal DBP is not a physiological determinant of pressor respon-
siveness to A 11.
Renal glycosuria and transplantation. A. Had] Aissa, N. Pozet, J. L.
Touraine, M. V. Pellet and J. Traeger. Service d'Exploration Fon-
ctionnelle Rénale, Clinique de Néphrologie et des Maladies Métabo-
liques, Hbpita/ E. Herriot, Lyon Cedex. France. The pathogenesis






of renal glycosuria (RG) remains uncertain: specific tubular dis-
ease or prediabetic state. Transplantation of such a kidney is a
unique opportunity to try to distinguish the anomaly of the kidney
itself from a possible metabolic general perturbation. A 35-yr-old
woman with end-stage chronic renal failure was successfully
treated by kidney transplantation from a HL-A A, B and D identi-
cal sibling. The 26-yr-old male donor had satisfactory radiological
and functional pretransplantation tests, aside from a slight obesity
and intermittent glycosuria. A normal high dose per os glucose
tolerance test (HPOGTT) with decreased minimal treshold (1.4
g/liter) and Tm glucose (172 mg/min/l.73 m') proved the exis-
tence of RG in the donor. This moderate RG did not seem to be a
contraindication to the kidney removal for transplantation. After
the transplantation, further investigations demonstrated no RG in
the recipient (one month after transplantation TmG = 260
mg/mm; two years after TmG = 150 mg/mm; and three years after
TmG = 209 mg/min/l.73 m2) who had a normal renal function
(one year after transplantation glomerular filtration rate 65
mI/mm, and three years after, GFR = 74 ml/min/l.73 m'). In the
donor, laboratory findings of RG disappeared, but distinct signs of
diabetes mellitus were noted (HPOGTT and insulinemia). These
results raise several questions concerning the pathogenesis of RG,
the relations between RG and diabetes mellitus, the adaptation of
tubular reabsorption of glucose to new conditions and the possible
role of nephrectomy in revealing a latent diabetes mellitus.
Effects of clopamide and furosemide on the blood urea of rats with
congenital diabetes insipidus. J. L. Imbs, M. Schmidt, A, Parrenin,
H. Belhadj-Mostefa and J. Schwartz. Inst. Pharmacologie. Fac.
Med. Strasbourg, France, The increase in blood urea produced by
diuretics is usually attributed to a reduction in extracellular fluid
volume. In Brattleboro rats with congenital diabetes insipidus,
diuretics increase natriuresis, but reduce polyuria. It is thus pos-
sible to study the action of diuretics on renal function in these
animals without affecting water balance, We compared the effect of
large doses (800 mg p.o.) of clopamide and furosemide. Blood urea
(urease micromethod) increased in all the animals, but the increase
was greater and more rapid with furosemide than with clopamide.
Four hours after administration of the diuretics, the urine flow had
dropped from 2.27 to 0.54 ml/lOO g of rat/hr with furosemide and
from 2.40 to 0.33 ml with clopamide, while the blood urea values
were 32.8 + 1.6 mg/I00 ml of plasma and 18.2 + 2.7 mg (P <
0.001), respectively. This greater increase in blood urea produced
by furosemide in the rat with diabetes insipidus without loss of
water would appear to be directly connected with its mode of
action on the nephron. These results supplement those obtained
with the Wistar rat with induced renal insufficiency (lmbs et al:
Thérapie 30:125, 1975), in which furosemide(5 mg/kg) reduced the
excretion of urea and creatinine in the urine more significantly than
clopamide (16 mg/kg), with the same natruretic effects.
Nephrographic patterns after high dose urography in acute renal
failure. J. .Joffre, D. Durand, J. L. Sablayrolles, J. Putois and J. M.
Sue. Service de Nèphrologie, Groupe INSERM U-133 and Service
de Radio/ogle, C.H. U. Rangueil, Toulouse, France. Seventy-five
patients presenting with acute renal failure were examined by iv.
urography according to the following method: a high dose of
contrast medium (2 mI/kg) was quickly injected iv. and early
tomograms adapted with circulation transit time were performed.
With this technique, a study of the vascularization and of the
different nephrographic stages was obtained. The patients were
divided into four groups: 1st group (18 cases): obstructive acute
renal failure: In 75% of these 18 patients, the diagnosis was made
by the visualization of intrarenal lacunae on early tomograms. 2nd
group (7 cases): acute renal failure of vascular origin: In all cases,
no cortical nephrography was noted. 3rd group (42 cases): acute
renal failure of parenchymatous origin: The orographic patterns
were homogeneous: in about 85% of the cases, the early cortical
nephrogram was good, and the late global nephrogram was dense
and persisting. This pattern was noted as well in acute tubular
necrosis as in acute glomerulonephritis. 4th group (8 cases): acute
transplant rejection: In 6 cases with severe acute rejection, the
nephrogram was faint and persisting. These observations are im-
portant for diagnosis and subsequent investigations, and in some
cases for establishing treatment.
Nonsystemic glomerular diseases and inhalation of organic sol-
vents. G. Lagrue, T. Kamalodine, J. Guerrero, F. Zhepova and J.
Bernaudin. Department of Nephrology and INSERM U 139, Hôpital
Henri-Mondor, Creteil, France. The possible role of exposure to
organic solvents and various inhaled toxic substances was studied
in 108 cases of nonsystemic chronic glomerulonephritis. The fre-
quency and intensity of exposure of the patients were compared to
those of a matched control population. The degree of exposure was
graded by a single investigator according to the method of Beirne
(scale I to 10, Lancet 2:199-201, 1975). An exposure to inhaled
toxic substances was found in 62% of the pathologic cases and in
only 28% of the controls. The degree of exposure was significantly
(P < 0.005) higher in the patient group (6.25 + 2.47) than in the
control group (3.90 + 1.85). When the patients were classified
according to histological findings, the frequency of exposure was
similar in all groups. Industrial substances (hydrocarbon solvents
chiefly, fuels and paints) were involved in most cases. These results
suggest that inhalation of organic solvents and other inhaled sub-
stances may participate in the pathogenesis of glomerular diseases.
The exact mechanism of this phenomenon remains unknown. A
direct toxic effect seems unlikely. A more attractive hypothesis
would be an alteration of the immune status of exposed patients.
Urinary excretion pattern of a pluridisperse protein solution. M.
Laurent and P. P. Lambert. Laboratory of Experimental Medicine,
Brussels University and Queen Elisabeth Foundation, Brugmann
Hospital, Brussels, Belgium. A pluridisperse solution of proteins
derived from gelatin (Haemacel, currently used as plasma ex-
pander) is separated by chromatography into two fractions (E. S.
radii (a,) of about 35 and 50 A) which are iodinated and mixed (2:1
ratio). A total of 200 mCi of '251-labelled Haemacel are infused iv.
in Nembutal-anesthetized dogs during classical clearance experi-
ments. The sieving coefficients (4') for each a, are derived from the
data of plasma and urine chromatography on Sephadex 0 200.
Mean maximum 4' (seven dogs) reached 0.240 (5FM, 0.070) for an
a, of 18.2 A (sEM, 0.7), whereas 4' of 0.95 or greater is reached for
the same a, with PVP. 'F decrease with increasing a,. Sieving
restriction owing to electrical charge f.i. or tubular reabsorption
may account for this difference. The latter is tested by trying to
saturate it with an unlabelled Haemacel overload (four experi-
ments). 'I' maximum increased from 0.117 (sEM, 0.029) to 0.347
(sEM, 0.037) (P < 0.001). Unlabelled Haemacel overload does not
equalize 18 A Haemacel molecules and inulin clearances; thus,
factors other than tubular reabsorption, perhaps electrical charges,
restrict H aemacel urinary excretion.
Membranous glomerulonephritis (MGN) with extrarenal dis-
orders in children. C. Kleinknecht, M. Levy, M. F. Gagnadoux and
R. Habib. Hôpital des Enfants-Malades, Paris, France. Extrarenal
disorders coexisted with nephropathy in 29 of 82 children with
MON. In 18 of these, the responsibility of a definite antigen (Ag)
can be suspected: (I) hepatitis B Ag (HBAg) in 6 children; 3 of
them presented with acute hepatitis and recovered from their neph-
ropathy despite the persistence of HBAg; (2) systemic lupus er-
ythematosus (2 cases); (3) sickle cell disease (I case) or trait (3
cases); (4) congenital syphilis in one infant who recovered after
penicillin therapy; (5) penicillamine therapy for Wilson's disease (I
case); (6) a streptococcal hypersensitivity suspected in 4 patients
who presented with scarlet fever (3 cases) or rheumatic fever (I
case). The associated findings in the II remaining patients sugges-
ted a multiorgan involvement due to circulating immune com-
plexes of unknown origin: thrombopenic purpura (I case); arth-
ralgias, myalgias, fever and purpura coexisting with the onset of
MGN, five years after remission of a myelomonocytic leukemia (I
case); proximal tubular dysfunction (2 cases) with presence of
antitubular and antilung basement membrane antibodies in the
child who underwent immunopathologic investigations; poly-
arthralgias with or without fever, and skin rashes (7 cases). Immu-
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nofluorescent studies showed the presence of IgG in li/Il patients
studied, ofC3 in 8/11, ofC4 in 2/8 and ofClq in 4/8. Plasma C3
was normal. Plasma Clq, C4 and C3PA were significantly lower
than in controls (mean values: 75 vs. 99%, 29 vs. 43 mg/100 ml, 18
vs. 26 mg/l00 ml). The immunopathologic findings did not differ
significantly from those observed in the apparently isolated MON.
Uremic neurotoxins. N. K. Man, G. Cue ille, J. Boudet, J. Zing-
raff, A. Becker, T. Driieke, P. Jungers, A. Sausse and J. L. Funck-
Brentano. Département de Nephrologie, Hbpiial Necker et Labora-
toires de Recherches, Rhône-Poulenc, Paris, France. Our previous
studies have shown a strong correlation between uremic neur-
opathy and plasma retention of solutes of middle molecular weight
range (300 to 2,000 daltons). In order to characterize the solute(s)
which might be responsible for uremic neuropathy, plasma sam-
ples of healthy subjects (N = 20), uncomplicated dialyzed patients(N = 47) and patients with progressive neuropathy were analyzed
by high performance gel chromatography and then by ion ex-
change chromatography. Comparison of chromatographic pat-
terns led us to isolate a fraction labeled "b4" which was found in
uniquely high concentration in plasma of neuropathic patients.
Further, fraction "b4" concentration decreased as the neurologic
status of patients improved when they were treated with an ade-
quate dialysis strategy. Amino-acid analysis of this fraction gave 10
to II amino acids which correspond to a total mol wt of 1187 to
1289 daltons. Purification of fraction "b4" by thin layer chroma-
tography on silica gel showed the presence of four organic solutes.
Only one is of polypeptidic nature. Neurotoxicity of total plasma
and chromatographic fractions was tested on isolated sural nerve
of Rana esculenta. No inhibition of the response to calibrated
stimulation was found when the nerve was incubated in normal
plasma or in plasma from uncomplicated dialyzed subjects. Total
plasma and fraction "b4" from neuropathic patients gave positive
results. Our data show new evidence that uremic neuropathy is due
to the plasma retention of neurotoxins of 1100 to 1300 mol wt.
Selective bilateral renal-artery embolization (RAE) as treatment
of malignant hypertension in two repetitive dialysis patients. J. J.
Merland, J. Rozlembourg, A. Jardin, P. Thibault, J. J. Rouby, C.
Jacobs, M. Legrain. Service de Nkphrologie et Clinique (Jrologique,
Hbpital de Ia Pitik.Paris, Cedex, France. Bilateral selective RAE
has been performed in two anuric repetitive dialysis patients for
whom adequate control of malignant hypertension could not be
obtained. The embolization procedure involved the use of the
Seldinger technique and material made of gelatine sponge, natural
thrombine and in one case polytef (Teflon) fragments. In both
patients RAE was followed by long-lasting (one week) lumbo-
abdominal pain and febrile reaction. Hyperkalemia (8.7
mEq/liter) occurred during the first hours after RAE in one pa-
tient. Such a complication was prevented in the second patient by
continuous peritoneal dialysis. In one patient normal blood pres-
sure without drugs was observed one month after RAE. Residual
plasma renin activity is 2 ng/ml/hr. In the other patient malignant
hypertension persisted, associated with very high renin activity, 120
ng/ml/hr. Subsequent bilateral nephrectomy was immediately ef-
ficient on blood pressure. Infarction of the kidneys was total on the
left side and partial on the right side. Selective RAE is able in some
instances of malignant hypertension to take the place of bilateral
nephrectomy. Some complications and incomplete results are to be
expected. Evaluation of the usefulness and limitations of the pro-
cedure requires more extensive investigations.
Hypertension of long-term hemodialysis patients: Studies with an
angiotensin II antagonist (P113). A. Mimran. S. Shaldon, C. Po-
lito, C. Mion, P. Barjon. Monipellier. Saralasin (P113) was used
to evaluate the role of angiotensin in ten hypertensive dialysis
patients (age, 28 to 58 yr) maintained on 3 X weekly hemodialysis
for 2 to 45 months. After a 30-mm control period, P113 was
infused iv. at a low dose (LDI), 0.52 /1g/kg/min for 30 mm,
followed by a high dose (HDI), 2.35 sg/kg/min for 30 mm. Blood
pressure (BP) was continuously measured with an arteriosonde.
1-lematocrit (Hct), plasma Na, plasma K and plasma renin
activity (PRA) were measured immediately before and at the end
of LDI and HDI periods. The study was performed four hours
before and repeated one hour after a four-hour hemodialysis
(HD). Before HD, control BP was 159 + 7/104 + 5 mm Hg (MAP,
123 5), LDI and HD P113 reduced MAP by 15 + 2(P <0.001)
and 17 + 3 mm Hg (P < 0.001), respectively, and PRA increased
from a control of 26 4 to 42 9 (LDI) and 40 9 ng/m I/hr
(HDI). HD induced a mean weight loss of 1.4 0.2 kg associated
with a MAP fall of 13 3 mm Hg (P < 0.01). After HD, saralasin
produced a similar fall in MAP and increase in PRA as before HD.
The hypotensive effect of P113 suggests that the endogenous angio-
tensin 11 pressor effect was responsible in part for the hypertension.
The P113 hypotensive effect together with the MAP reduction
during HD suggest that hypertension in dialysis patients is main-
tained by volume and vasoconstrictor factors. However, two
patients did not respond to P113 but one had a marked drop in BP
with HD alone, suggesting that hypertension may also be totally
volume-dependent. P113 may be of clinical value in the assessment
of the ultrafiltration requirement for BP control.
Angiotensin receptors in different target organs. Marie-Gabrielle
Pernollet, Marie-A ude Devynck and Philippe Meyer. Physiologie
and Pharmacologie, INSERM (17, Hbpital Necker, Paris, France.
Having at our disposition a radioactive angiotensin of high spe-
cific activity possessing all the biological activity of the unlabelled
hormone has permitted the study of the interaction of the hormone
with its specific receptor sites. Such studies have been carried out at
the level of different target organs: the rabbit aorta has been taken
as a model of vascular smooth muscle, the rat uterus as a model of
nonvascular smooth muscle and, finally, the binding of angiotensin
11 has also been studied in the rat adrenal glands. The properties of
the binding sites for angiotensin in these different tissues have been
compared—with particular reference to their cellular localization,
the kinetic characteristics of the binding and their specificity vis a
vis different structural analogues of angiotensin II. Finally, the
problem of a possible regulation of the binding capacity of the
target cells as a function of levels of circulating hormone has been
studied in two of these tissues. After renin suppression by bineph-
rectomy, there appears to be a modification of the binding capacity
of isolated membranes of uterus and adrenals. The characteristics
of these different binding sites and their behavior after dis-
appearance of the endogenous hormone are analogous to those
already described in other quite different hormone-receptor sys-
tems.
An experimental model of massive proteinuria in the dog. J. Sa-
dowski and P. P. Lambert. Queen Elisabeth Medical Foundation,
Brussels, Belgium. A concentrated urea solution (8M) was used by
Kefalides and Winzler (1966) to solubilize in vitro the renal gb-
merular basement membrane. In the present study an attempt was
made to utilize this property of urea for modification of glomerular
permeability in vivo. In nine pentobarbital-anesthetized dogs,
the left renal artery was clamped at the aorta for five minutes
and 10 ml of 4M urea in a I : I mixture of plasma and water was
injected into the kidney during three minutes. A further two min-
utes were allowed for urea to remain in contact with kidney tissue
before release of the clamp. Simultaneously, a five-minute total
renal ischemia was produced in the contralateral control kidney by
inflating a catheter baloon appropriately positioned in the aorta.
Protein excretion increased from a control of 0.6 + (sEM) 0.2 to 4.8
+ 1.6 mg/mm for the urea-perfused but remained unchanged for
the control kidney. Renal clearances of inulin and para-aminohip-
purate (PAH) of the experimental kidney decreased 24 and 42%,
respectively. The extraction ratio of PAH fell 12% on the average.
The Sephadex gel filtration and electrophoresis of urinary proteins
disclosed a pattern of nonselective glomerular proteinuria. Elec-
tron microscopic studies and investigations of glomerular perme-
ability to neutral macromolecules are in course. The developed
model of acute unilateral nephrotic-like syndrome enables mor-
phologic and physiopathologic studies of the early stage of massive
proteinuria in the dog.
Detection of CIq binding substances in sera of patients with glome-
rulonephritis. A lain T. Sobel, Danièle Dechatrette and Gilbert
Lagrue. INSERM U 139, Department ofNephrology, Henri-Mon-
dor Hospital, Creteil, France. Participation of immune complexes
and complement in the pathogenesis of a variety of glomerulone-
phritides has been established. Clq, being the recognition protein
of the classical complement system, has proved to be a sensitive
detector of immune complexes and other complement-reactive ma-
terials in serum. We recently developed the Clq deviation test (J
Exp Med 142:139, 1975), which quantitates the interference of
immune complexes (AgAb) with (1251) Clq binding to sensitized
sheep erythrocytes (EA). In a mixture of EA, AgAb and Clq, a
proportion ofClq is deviated and bound by the complexes: AgAb
+ EA + CIq —' AgAb Clq + EA Clq + Clq. Separation of cell-
bound and fluid phase Clq is accomplished by an original method
allowing excellent accuracy and reproducibility. The C lq deviation
test is rapid, simple and sensitive. It allows the detection in human
serum of SlAg/mI of gamma-globulin aggregates or BSA-antiBSA
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complexes; 10 lAg/mI of native or single-stranded DNA, 35 lAg/mI
of certain Clq-reactive endotoxins. One hundred ninety-seven sera
from 144 patients were tested. '251-Clq binding to EA in patholog-
ical sera was compared to the binding in normal human serum. A
Clq deviation of 15% or more was considered to be a positive
result. Sera from patients with AGN, membranous GN, minimal
change disease and membranoproliferative GN displayed a Clq
deviation in 78%, 46%, 30% and 22% of the cases, respectively. In
contrast, positive results were observed in only 12% of the patients
with hypertension and 8% of the cases with mesangial IgA depos-
its. Sera of 17 presumably normal controls were negative, as well as
sera from patients with various kidney diseases such as myeloma,
renal amyloidosis, gout and lithiasis. Except in AGN cases, the
degree of Clq deviation was low. These results suggest that Clq
deviation in sera of patients with glomerulonephritis may be due to
immune complexes but also to other unknown substances. They
emphasize the necessity of isolating and biochemically character-
izing Clq-reactive materials in pathological sera.
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